ClinicalTrials.gov
public full text
Public Domain
Diclofenac for Prevention of Post-ERC Pancreatitis
The study aims at assessing the effectiveness of Diclofenac for prevention of post-ERCP pancreatitis. It will be undertaken embedded in the Swedish national register for Gallstone surgery and ERCP (GallRiks). Patients are randomised to Diclofenac prior to the ERCP or no prophylaxis. GallRiks is used to identify which patients fulfill the eligibility criteria and which patients develop pancreatitis after the ERCP.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease#900131
- Treating Acute Pancreatitis With Dabigatran, a Pilot Study#810116
- Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis#1074666
- Clinical Usefulness of Cortisol, Antinuclear Antibodies and High-sensitivity C-reactive Protein in Acute Pancreatitis#1087284
- Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic#844613
Record · ID 993706
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive